BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 118450
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118450
Table 6 Frequency (and percentage) of key adverse clinical outcomes observed within each immunologic risk cluster, n (%)
Cluster
Acute rejection
Graft loss
Delayed graft function
Mortality
High risk cluster4 (6.9)4 (6.9)2 (3.4)3 (5.2)
Intermediate risk 0 (0.0)2 (5.9)2 (5.9)2 (5.9)
Low risk cluster 1 (5.0)0 (0.0)0 (0.0)0 (0.0)


Write to the Help Desk